A citation-based method for searching scientific literature

Sarmadia Ashraf, Shahnaz Qadri, Shayista Akbar, Aijaz Parray, Yousef Haik. Adv Biol (Weinh) 2022
Times Cited: 3







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Understanding Suboptimal Response to Immune Checkpoint Inhibitors.
Mojun Zhu, Henan Zhang, Katrina S Pedersen, Nathan R Foster, Brandy L Jaszewski, Xin Liu, Jacob B Hirdler, Zesheng An, Tanios S Bekaii-Saab, Thorvardur R Halfdanarson,[...]. Adv Biol (Weinh) 2022
3
66

Breakthrough in targeted therapy for non-small cell lung cancer.
Zhencong Ye, Yongmei Huang, Jianhao Ke, Xiao Zhu, Shuilong Leng, Hui Luo. Biomed Pharmacother 2021
28
66

piRNAs: biogenesis and their potential roles in cancer.
Binghong Guo, Dongpei Li, Likun Du, Xiao Zhu. Cancer Metastasis Rev 2020
57
66

How to overcome the side effects of tumor immunotherapy.
Shang Li, Zhibi Zhang, Wing-Fu Lai, Liao Cui, Xiao Zhu. Biomed Pharmacother 2020
23
66

Circular RNAs: The star molecules in cancer.
Jianhong Liu, Dongpei Li, Hui Luo, Xiao Zhu. Mol Aspects Med 2019
102
66

New insights into molecules and pathways of cancer metabolism and therapeutic implications.
Zhenye Tang, Zhenhua Xu, Xiao Zhu, Jinfang Zhang. Cancer Commun (Lond) 2021
28
66


The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges.
Shimin Xie, Zhengguo Wu, Yi Qi, Binhua Wu, Xiao Zhu. Biomed Pharmacother 2021
24
66

DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine.
Runzhang Liang, Xiaosong Li, Weiquan Li, Xiao Zhu, Chen Li. Biomed Pharmacother 2021
19
66

Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment.
Jia Xiong, Hui Wang, Qingqing Wang. Adv Biol (Weinh) 2021
6
66

Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer.
Xiaoxiao Liu, Zhang Li, Yuexiang Wang. Adv Biol (Weinh) 2021
7
66

Cancer immunotherapy: Pros, cons and beyond.
Shuzhen Tan, Dongpei Li, Xiao Zhu. Biomed Pharmacother 2020
134
66

The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Peng Han, Jing-Wen Li, Bo-Miao Zhang, Jia-Chen Lv, Yong-Min Li, Xin-Yue Gu, Zhi-Wei Yu, Yun-He Jia, Xue-Feng Bai, Li Li,[...]. Mol Cancer 2017
328
33

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Tong Liu, Xin Zhang, Lutao Du, Yunshan Wang, Xiaoming Liu, Hui Tian, Lili Wang, Peilong Li, Yinghui Zhao, Weili Duan,[...]. Mol Cancer 2019
183
33

Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence.
Ben Sang, Yuan Yuan Zhang, Su Tang Guo, Ling Fei Kong, Qiong Cheng, Guang Zhi Liu, Rick F Thorne, Xu Dong Zhang, Lei Jin, Mian Wu. Proc Natl Acad Sci U S A 2018
45
33

NK cell surveillance of hematological malignancies. Therapeutic implications and regulation by chemokine receptors.
Luana Tomaipitinca, Eleonora Russo, Giovanni Bernardini. Mol Aspects Med 2021
1
100

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer.
C Allison Stewart, Carl M Gay, Yuanxin Xi, Santhosh Sivajothi, V Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M Hartsfield, Veerakumar Balasubramaniyan, Milind D Chalishazar,[...]. Nat Cancer 2020
103
33

ERBB receptors and cancer: the complexity of targeted inhibitors.
Nancy E Hynes, Heidi A Lane. Nat Rev Cancer 2005
33

The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Sepideh Mirzaei, Mohammad Hossein Gholami, Kiavash Hushmandi, Farid Hashemi, Amirhossein Zabolian, Israel Canadas, Ali Zarrabi, Noushin Nabavi, Amir Reza Aref, Francesco Crea,[...]. J Hematol Oncol 2022
23
33

Brilliant glycans and glycosylation: Seq and ye shall find.
Guanwen Gao, Chen Li, Wenguo Fan, Mingtao Zhang, Xinming Li, Wenqing Chen, Weiquan Li, Runzhang Liang, Zesong Li, Xiao Zhu. Int J Biol Macromol 2021
10
33

Informing the new developments and future of cancer immunotherapy : Future of cancer immunotherapy.
Atul Kumar, Courtney A Swain, Lalita A Shevde. Cancer Metastasis Rev 2021
5
33

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kazuhiko Nakagawa, Edward B Garon, Takashi Seto, Makoto Nishio, Santiago Ponce Aix, Luis Paz-Ares, Chao-Hua Chiu, Keunchil Park, Silvia Novello, Ernest Nadal,[...]. Lancet Oncol 2019
263
33

Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells.
Amila K Nanayakkara, Courtney A Follit, Gang Chen, Noelle S Williams, Pia D Vogel, John G Wise. Sci Rep 2018
132
33

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges.
Zhilin Zou, Tao Tao, Hongmei Li, Xiao Zhu. Cell Biosci 2020
196
33

Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
David Cella, Robert J Motzer, Cristina Suarez, Steven I Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel F Wallace, Burcin Simsek, Joshua Zhang, Cristina Ivanescu,[...]. Lancet Oncol 2022
12
33

Visiting "noncodarnia".
Jeffrey M Perkel. Biotechniques 2013
165
33

A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer.
Alexander Drilon, Romel Somwar, Jacob P Wagner, Nadeem A Vellore, Christopher A Eide, Matthew S Zabriskie, Maria E Arcila, Jaclyn F Hechtman, Lu Wang, Roger S Smith,[...]. Clin Cancer Res 2016
105
33

GWAS in cancer: progress and challenges.
Baiqiang Liang, Hongrong Ding, Lianfang Huang, Haiqing Luo, Xiao Zhu. Mol Genet Genomics 2020
35
33

Dissecting Therapeutic Resistance to ERK Inhibition.
Sharda Jha, Erick J Morris, Alan Hruza, My Sam Mansueto, Gottfried K Schroeder, Jaren Arbanas, Daniel McMasters, Clifford R Restaino, Priya Dayananth, Stuart Black,[...]. Mol Cancer Ther 2016
34
33

The role of exosomes and miRNAs in drug-resistance of cancer cells.
Duc-Hiep Bach, Ji-Young Hong, Hyen Joo Park, Sang Kook Lee. Int J Cancer 2017
159
33

The cancer exosomes: Clinical implications, applications and challenges.
Zhenye Tang, Dongpei Li, Shengping Hou, Xiao Zhu. Int J Cancer 2020
56
33

Immunometabolism of regulatory T cells in cancer.
Mario Galgani, Sara Bruzzaniti, Claudia La Rocca, Teresa Micillo, Paola de Candia, Maurizio Bifulco, Giuseppe Matarese. Mol Aspects Med 2021
6
33

Activation of RAS family members confers resistance to ROS1 targeting drugs.
Marilisa Cargnelutti, Simona Corso, Margherita Pergolizzi, Laurence Mévellec, Dara L Aisner, Rafal Dziadziuszko, Marileila Varella-Garcia, Paolo M Comoglio, Robert C Doebele, Jorge Vialard,[...]. Oncotarget 2015
60
33

RNA-based pharmacotherapy for tumors: From bench to clinic and back.
Xiangping Liang, Dongpei Li, Shuilong Leng, Xiao Zhu. Biomed Pharmacother 2020
37
33

BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review.
Xin An, Amit K Tiwari, Yibo Sun, Pei-Rong Ding, Charles R Ashby, Zhe-Sheng Chen. Leuk Res 2010
192
33

Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression.
Sachiko Taniguchi, Ajit Elhance, Avery Van Duzer, Sushil Kumar, Justin J Leitenberger, Naoki Oshimori. Science 2020
71
33

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.
Rafal Dziadziuszko, Anh T Le, Anna Wrona, Jacek Jassem, D Ross Camidge, Marileila Varella-Garcia, Dara L Aisner, Robert C Doebele. J Thorac Oncol 2016
54
33


Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy.
Maria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, Janis M Taube, Tracee L McMiller, Alan E Berger, Jinshui Fan, Genevieve J Kaunitz, Tricia R Cottrell, Zachary A Kohutek,[...]. Clin Cancer Res 2017
52
33

Sensory Neurotransmitter Calcitonin Gene-Related Peptide Modulates Tumor Growth and Lymphocyte Infiltration in Oral Squamous Cell Carcinoma.
Lisa A McIlvried, Megan A Atherton, Nicole L Horan, Tori N Goch, Nicole N Scheff. Adv Biol (Weinh) 2022
2
50

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
Jeffrey A Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Youngchul Song, Courtney Hyland, Joon Oh Park, Neal Lindeman, Christopher-Michael Gale, Xiaojun Zhao, James Christensen,[...]. Science 2007
33

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain.
William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus. PLoS Med 2005
33

Afatinib restrains K-RAS-driven lung tumorigenesis.
Herwig P Moll, Klemens Pranz, Monica Musteanu, Beatrice Grabner, Natascha Hruschka, Julian Mohrherr, Petra Aigner, Patricia Stiedl, Luka Brcic, Viktoria Laszlo,[...]. Sci Transl Med 2018
77
33

Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells.
Jing-Jing Mou, Jin Peng, Ying-Ying Shi, Na Li, You Wang, Yuan Ke, Yun-Feng Zhou, Fu-Xiang Zhou. Biomed Pharmacother 2018
16
33

Non-coding RNAs and macrophage interaction in tumor progression.
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, Sholeh Etehad Asnaf, Afshin Taheriazam, Mehrdad Hashemi, Milad Ashrafizadeh, Ali Zarrabi, Navid Rabiee, Kiavash Hushmandi,[...]. Crit Rev Oncol Hematol 2022
5
33

Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?
Imen Jridi, Kirsten Canté-Barrett, Karin Pike-Overzet, Frank J T Staal. Front Cell Dev Biol 2021
27
33

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape.
Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu, Sjoukje J C van der Stegen, Theodoros Giavridis, Jorge Mansilla-Soto, Justin Eyquem, Zeguo Zhao, Benjamin M Whitlock, Matthew M Miele,[...]. Nature 2019
236
33

Noncoding RNA therapeutics - challenges and potential solutions.
Melanie Winkle, Sherien M El-Daly, Muller Fabbri, George A Calin. Nat Rev Drug Discov 2021
256
33

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Brian I Rini, Elizabeth R Plimack, Viktor Stus, Rustem Gafanov, Robert Hawkins, Dmitry Nosov, Frédéric Pouliot, Boris Alekseev, Denis Soulières, Bohuslav Melichar,[...]. N Engl J Med 2019
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.